These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2871235)

  • 21. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
    Brawley L; Shaw AM; MacDonald A
    Br J Pharmacol; 2000 Feb; 129(4):637-44. PubMed ID: 10683187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.
    Steinkraus V; Nose M; Scholz H; Thormählen K
    Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs.
    Takayanagi I; Koike K
    Gen Pharmacol; 1985; 16(3):265-7. PubMed ID: 2862092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
    Keith RA; Hwang TF; Murthy VS; Kau ST; Salama AI; Giles RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):240-8. PubMed ID: 2563288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of (+)- and (-)-amosulalol on the rat isolated right ventricle.
    Doggrell SA
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):213-8. PubMed ID: 2436001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
    Chen IJ; Yeh JL; Lo YC; Sheu SH; Lin YT
    Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro myocardial depression by ketamine or thiopental is dependent on the underlying beta-adrenergic tone.
    Thurston TA; Mathew BP
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):338-41. PubMed ID: 8721465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of (+/-)-, (+)- and (-)-celiprolol and bromoacetylalprenololmentane at the beta-adrenoceptors of rat isolated cardiovascular preparations.
    Doggrell SA
    J Pharm Pharmacol; 1990 May; 42(5):319-24. PubMed ID: 1976778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence that (+/-)-carteolol-induced relaxation is mediated by beta2-adrenoceptors but not by beta3-adrenoceptors in the guinea pig taenia caecum.
    Horinouchi T; Koike K
    J Smooth Muscle Res; 2000 Oct; 36(5):145-53. PubMed ID: 11286298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of the effects of OPC-1085 and propranolol on isolated guinea pig atrium.
    Imanaga I; Sakamoto Y; Tomita T
    Jpn J Pharmacol; 1977 Apr; 27(2):227-32. PubMed ID: 18629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inotropic beta-blocking potency (pA2) and partial agonist activity of propranolol, practolol, sotalol and acebutolol.
    Lewis MJ; Grey AC; Henderson AH
    Eur J Pharmacol; 1982 Dec; 86(1):71-6. PubMed ID: 6130956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac responsiveness after acute withdrawal of chronic propranolol treatment in rats.
    Kennedy RH; Donnelly TE
    Gen Pharmacol; 1982; 13(3):231-9. PubMed ID: 6124482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICI 147,798 causes insurmountable antagonism against T-0509, a selective beta 1-adrenoceptor agonist, but surmountable antagonism against isoproterenol.
    Tofukuji M; Yanagisawa T; Kurosawa H; Ishii K; Taira N
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):323-31. PubMed ID: 7679169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of KF-4317, a novel combined alpha- and beta 1-adrenoreceptor antagonist, on the rat isolated right ventricle and aorta.
    Doggrell SA; Hughes EW
    J Auton Pharmacol; 1986 Mar; 6(1):25-32. PubMed ID: 2870068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha1-adrenoceptor antagonist effect of (+/-)-dobutamine in rat isolated gastric artery preparation.
    Oriowo MA
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):728-33. PubMed ID: 10547090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.